Effect of a mistletoe extract (Iscador® QuFrF) on viability and migratory behavior of human peripheral CD4+ and CD8+ T lymphocytes in three-dimensional collagen lattices

In Vitro Cellular and Developmental Biology - Animal

Volumn 33, Issue 9, 1997, Pages 710-716

  Nikolai, G ^a   Friedl, P ^a,b   Werner, M ^c   Niggemann, B ^a   Zanker K S ^a,b  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b MCGILL UNIVERSITY   (Canada)

^c Verein fur Krebsforschung   (Switzerland)

Author keywords

Collagen matrix; Migration; Mistletoe extract; T lymphocyte; Viability

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; COLLAGEN GEL;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FETAL CALF SERUM; HUMAN; HUMAN CELL; LYMPHOCYTE MIGRATION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VISCUM ALBUM;

VISCUM ALBUM;

EID: 0030660248     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-997-0129-8     Document Type: Article

References (26)

1. + splenic T cells after CD28 receptor ligation. J. Immunol. 154:985-997; 1995.
2. + T lymphocytes stimulated by the lectin jacalin. Eur. J. Immunol. 25:2010-2018; 1995.
3. Blin, N.; Stafford, D. W. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res. 3:2303-2308; 1976.
4. Boyden, S. V. The chemotactic effect of mixture of antibody and antigen on polymorphonuclear leukocytes. J. Exp. Med. 115:453; 1962.
5. Citores, L.; Ferreras, J. M.; Iglesias, R., et al. Molecular mechanism of inhibition of mammalian protein synthesis by some four-chain agglutinins. FEBS Lett. 329:59-62; 1993.
6. Friedl, P.; Noble, P. B.; Zänker, K. S. Lymphocyte locomotion in three-dimensional collagen gels. Comparison of three quantitative methods for analyzing cell trajectories. J. Immunol. Methods 165:157-165; 1993.
7. + lymphocytes in three-dimensional collagen lattices. Immunology 82:611-624; 1994.
8. Gabius, H.-J.; Gabius, S. Wohin führt die naturwissenschaftliche Forschung über Misteltherapie? Dtsch. Arztebl. 91:1511-1515; 1994.
9. Hajto, T. Immunomodulatory effects of Iscador: a Viscum album preparation. Oncology 43 (suppl. 1):51-65; 1986.
10. Hajto, T.; Hostanska, K.; Frei, K., et al. Increased secretion of tumor necrosis factor α, interleukin 1, and interleukin-6 by human mononuclear cells exposed to β-galactoside-specific lectin from clinically applied mistletoe extract. Cancer Res. 50:3322-3326; 1990.
11. Hajto, T.; Hostanska, K.; Gabius, H.-J. Modulatory potency of the β-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients. Cancer Res. 49:4803-4808; 1989.
12. Holtskog, R.; Sandvig, K.; Olsnes, S. Characterization of a toxic lectin in Iscador, a mistletoe preparation with alleged cancerostatic properties. Oncology 45:172-179; 1988.
13. Janssen, O.; Scheffler, A.; Kabelitz, D. In vitro effects of mistletoe extracts and mistletoe lectins. Arzneim. Forsch. Drug Res. 43:1221-1227; 1993.
14. Jung, M. L.; Baudino, S.; Ribéreau-Gayon, G., et al. Characterization of cytotoxic proteins from mistletoe (Viscum album L.). Cancer Lett. 51:103-108; 1990.
15. Kissel, D. Misteltherapie. In: Wrba, H., ed. Kombinierte Tumortherapie: Grundlagen, Möglichkeiten und Grenzen adjuvanter Methoden. Stuttgart, Germany: Hippokrates Verlag; 171-175; 1990.
16. Kopp, J.; Körner, I.-J.; Pfüller, U., et al. Toxicity of mistletoe lectins I, II and III on normal and malignant cells. In: Van Driessche, E.; Franz, H.; Beeckmans, S., et al., ed. Lectins: biology, biochemistry, clinical biochemistry. Vol. 8. Hellerup, Denmark: Textop: 41-47; 1993.
17. Mossmann, T. R.; Cherwinsky, H.; Bond, M. W., et al. Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-2357; 1986.
18. Muirhead, K. A.; Wallace, P. K.; Schmitt, T. C., et al. Methological considerations for implementation of lymphocyte subset analysis in a clinical reference laboratory. Ann. NY Acad. Sci. 68:113-127; 1986.
19. Newman, J.; Wilkinson, P. C. Methods for phenotyping polarized and locomotor human lymphocytes J. Immunol. Methods 147:43-50; 1992.
20. Nikolai, G.; Friedl, P.; Noble, P. B., et al. Induction of T lymphocyte locomotion via CD2 and CD3, but not via CD3 alone. Immunobiology 194:271; 1995.
21. Noble, P. B.; Levine, M. D. Computer-assisted analyses of cell locomotion and chemotaxis. Boca Raton, FL: CRC Press; 1986.
22. Ribéreau-Gayon, G.; Jung, M.-L.; Di Scala; D., et al. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells. Oncology 43 (suppl. 1):35-41; 1986.
23. H2 subsets: doubts no more. Immunol. Today 12:256-257; 1991.
24. Salzer, G.; Hellan, J.; Babits, R., et al. Die Mistel am Ludwig-Boltzmann-Institut für klinische Onkologie. Dtsch. Z. Onkol. 3:59-63; 1987.
25. Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-314; 1994.
26. Stettin, A.; Schultz, J. L.; Stechemesser, E., et al. Anti-mistletoe lectin antibodies are produced in patients during therapy with an aqueous mistletoe extract derived from Viscum album L. and neutralize lectin-induced cytotoxicity in vitro. Klin. Wochenschr. 68:896-900; 1990.